SMT201500221B - Nuovi derivati 6,11-diidro-5h-benzo[d]imidazo[1,2-a]azepinici come ligandi del recettore per l'istammina h4 - Google Patents

Nuovi derivati 6,11-diidro-5h-benzo[d]imidazo[1,2-a]azepinici come ligandi del recettore per l'istammina h4

Info

Publication number
SMT201500221B
SMT201500221B SM201500221T SM201500221T SMT201500221B SM T201500221 B SMT201500221 B SM T201500221B SM 201500221 T SM201500221 T SM 201500221T SM 201500221 T SM201500221 T SM 201500221T SM T201500221 B SMT201500221 B SM T201500221B
Authority
SM
San Marino
Prior art keywords
imidazo
benzo
dihydro
new
receptor ligands
Prior art date
Application number
SM201500221T
Other languages
English (en)
Italian (it)
Inventor
Bertrand Isabelle Berrebi
Xavier Billot
Thierry Calmels
Marc Capet
Stephane Krief
Olivier Labeeuw
Jeanne-Marie Lecomte
Nicolas Levoin
Xavier Ligneau
Phillipe Robert
Jean-Charles Schwartz
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of SMT201500221B publication Critical patent/SMT201500221B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201500221T 2012-06-05 2015-09-18 Nuovi derivati 6,11-diidro-5h-benzo[d]imidazo[1,2-a]azepinici come ligandi del recettore per l'istammina h4 SMT201500221B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12305633.5A EP2671883A1 (en) 2012-06-05 2012-06-05 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands

Publications (1)

Publication Number Publication Date
SMT201500221B true SMT201500221B (it) 2015-10-30

Family

ID=48534298

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500221T SMT201500221B (it) 2012-06-05 2015-09-18 Nuovi derivati 6,11-diidro-5h-benzo[d]imidazo[1,2-a]azepinici come ligandi del recettore per l'istammina h4

Country Status (11)

Country Link
US (1) US9255101B2 (xx)
EP (2) EP2671883A1 (xx)
CY (1) CY1116563T1 (xx)
DK (1) DK2671884T3 (xx)
ES (1) ES2540976T3 (xx)
HR (1) HRP20150673T1 (xx)
PL (1) PL2671884T3 (xx)
PT (1) PT2671884E (xx)
RS (1) RS54080B1 (xx)
SI (1) SI2671884T1 (xx)
SM (1) SMT201500221B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
JP2012525386A (ja) 2009-05-01 2012-10-22 アエリエ・ファーマシューティカルズ・インコーポレーテッド 疾患の治療のための二重機構阻害剤
US20140275160A1 (en) 2013-03-15 2014-09-18 Aerie Pharmaceuticals, Inc. Combination therapy
PE20181145A1 (es) 2015-07-24 2018-07-17 Basf Se Compuestos de piridina
AU2016316784B2 (en) 2015-09-03 2020-10-22 BASF Agro B.V. Microparticle compositions comprising saflufenacil
CN108137533A (zh) 2015-10-05 2018-06-08 巴斯夫欧洲公司 防治植物病原性真菌的吡啶化合物
US9643927B1 (en) * 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
CA3035566A1 (en) 2016-08-31 2018-03-08 Aerie Pharmaceuticals, Inc. Ophthalmic compositions
WO2018054723A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054721A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054711A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018065182A1 (en) 2016-10-04 2018-04-12 Basf Se Reduced quinoline compounds as antifuni agents
WO2018073110A1 (en) 2016-10-20 2018-04-26 Basf Se Quinoline compounds as fungicides
CN106632061B (zh) * 2016-11-23 2020-07-24 上海皓元医药股份有限公司 一种1-(4-苯基-1-烷基-1h-咪唑-2-基)乙酮及其衍生物的合成方法
US20190359589A1 (en) 2017-01-23 2019-11-28 Basf Se Fungicidal pyridine compounds
KR20190135027A (ko) 2017-03-31 2019-12-05 에어리 파마슈티컬즈, 인코포레이티드 아릴 시클로프로필-아미노-이소퀴놀리닐 아미드 화합물
EP3606914A1 (en) 2017-04-06 2020-02-12 Basf Se Pyridine compounds
CA3084405A1 (en) 2017-12-15 2019-06-20 Basf Se Fungicidal mixture comprising substituted pyridines
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN112876436B (zh) * 2021-03-01 2022-06-21 安徽金轩科技有限公司 一种高选择性制备呋喃铵盐的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002007A1 (es) * 2006-07-11 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu

Also Published As

Publication number Publication date
US9255101B2 (en) 2016-02-09
DK2671884T3 (en) 2015-06-29
EP2671883A1 (en) 2013-12-11
EP2671884A1 (en) 2013-12-11
EP2671884B1 (en) 2015-03-25
PT2671884E (pt) 2015-07-30
ES2540976T3 (es) 2015-07-15
US20130324506A1 (en) 2013-12-05
RS54080B1 (en) 2015-10-30
HRP20150673T1 (hr) 2015-07-31
SI2671884T1 (sl) 2015-07-31
CY1116563T1 (el) 2017-03-15
PL2671884T3 (pl) 2015-08-31

Similar Documents

Publication Publication Date Title
SMT201500221B (it) Nuovi derivati 6,11-diidro-5h-benzo[d]imidazo[1,2-a]azepinici come ligandi del recettore per l'istammina h4
ZA201704808B (en) Cytotoxic benzodiazepine derivatives
IL234485A (en) Compounds based on imidazo [2,1 – b] pyridazine
HK1211208A1 (en) Cytotoxic benzodiazepine derivatives
HK1210139A1 (en) Novel benzimidazole derivatives as ep4 antagonists ep4
EP2887807A4 (en) NOVEL DERIVATIVES OF BENZIMIDAZOLE HEXAHYDROFURO [3,2-B] FURANE
HK1212328A1 (en) Bicyclic aza compounds as muscarinic m1 receptor agonists m1
EP2935264A4 (en) BICYCLIC 1,4-PYRIDONE HETEROARYL COMPOUNDS
CO7071124A2 (es) Pirazolo[1,5-a]piridina sustituida como inhibidores del receptor de cinasa tropomiosina (trk)
IL227496B (en) Pyrazolo[4,3–b]pyridines are converted as drugs
EP2935214A4 (en) 1,4-PYRIDONES COMPOUNDS
PT3041843T (pt) Derivados de triazolo[4,5-d]pirimidina como agonistas do recetor cb2
ZA201507389B (en) 2-phenyl or 2-hetaryl imidazol[1,2-a]pyridine derivatives
IL242162B (en) Pyrrolo [2, 3 –d] pyrimidine derivatives as 2cb receptor agonists
SMT201600262B (it) Derivati benzazolici come ligandi del recettore h4 dell'istamina
CO7010832A2 (es) Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina
EP2824108A4 (en) TETRACYCLIC ANTHRACHINONE DERIVATIVES
IL236473B (en) 1, 5-dihydro-2-pyrrole-one derivatives as cholecystokinin receptor ligands
SMT201700032B (it) Nuovi derivati di (aza)benzidril etere, loro processo di preparazione, e loro uso come ligandi del recettore h4 per applicazioni terapeutiche
GB201502644D0 (en) Bicyclic aza compounds as muscarinic m1 receptor agonists
EP2912169A4 (en) ARTEMISININE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS ANTIMALARIAMIDAL
ZA201505135B (en) Cytotoxic benzodiazepine derivatives
GB201221462D0 (en) Novel isothiazolo[5,4-b]pyridines
GB201213663D0 (en) Novel isothiazolo[5,4-b]pyridines